Dr. Bril is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 6th Ave S
Birmingham, AL 35233Phone+1 205-934-9999Fax+1 205-975-6424
Education & Training
- OtherClass of 2007
Certifications & Licensure
- AL State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Role of Hepatic Glycogen on Nocturnal Gluconeogenesis in Type 2 Diabetes Mellitus.Uma S Unni, Fernando Bril, John P Mugler 3rd, Rickey E Carter, Ananda Basu
The Journal of Clinical Endocrinology and Metabolism. 2025-02-04 - Population-Based vs. Health System and Insurer Records: Significant Underdiagnosis of Pcos - A Systematic Review.Sana Hatoum, Mina Amiri, Dawnkimberly Hopkins, Richard P Buyalos, Fernando Bril
The Journal of Clinical Endocrinology and Metabolism. 2025-01-21 - Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD.Diana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Fernando Bril, Philippe Huot-Marchand
Journal of Hepatology. 2025-01-15
Press Mentions
- PracticeUpdateDecember 3rd, 2020
- FDA Approves Rezdiffra, the First Drug for Diabetes-Related Liver DiseaseMarch 16th, 2024
Professional Memberships
- Member
- Member
External Links
- Publonshttps://publons.com/researcher/1216548/fernando-bril/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: